A study based on a survey of 50 adults linked poorer quality sleep with more depressive symptoms and respiratory issues in ...

The author highlights the real-life impacts on the residents of Knoxville and East Tennessee from Trump administration cuts ...

Spinal muscular atrophy (SMA) therapy Spinraza has been a key earner for Biogen in recent years, but with sales now heading into reverse, the company is looking to extend its franchise.

It's one of three drugs approved for SMA, the others being nusinersen (Spinraza) and onasemnogene abeparvovec (Zolgensma). In the St. Jude's case, the child was at risk for type 1 SMA, a severe ...

At the company’s direction, Malone said, their model mainly compared Zolgensma to the only other SMA treatment then on the market, a chronic treatment called Spinraza. It, too, was pricey ...

The two other SMA stalwarts on the market, Biogen’s oligonucleotide Spinraza and Novartis’ gene therapy Zolgensma, are delivered intrathecally (into the cerebrospinal fluid around the spinal ...

Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and ...

Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and ...

The approval of this new tablet builds on previous successes in SMA treatment, joining the existing oral liquid version of risdiplam (Evrysdi), as well as Biogen’s nusinersen (Spinraza ...